Blar i NTNU Open på forfatter "Håland, Erling"

Viser treff 1-4 av 4

    • Antimicrobial therapy for bloodstream infections in a low resistance environment: A retrospective observational study 

      Grøv, Kornelius; Håland, Erling (Master thesis, 2022)
      Formål: Karakterisere alle blodstrømsinfeksjoner ved et sykehus i Norge i løpet av 2019 med tanke på valg av empirisk antimikrobiell behandling, deeskaleringsstrategier og mortalitet. Metode: Retrospektiv observasjonsstudie ...

    • Smac-mimetics reduce numbers and viability of human osteoclasts 

      Moen, Ingrid Nyhus; Westhrin, Marita; Håland, Erling; Haug, Markus; Nonstad, Unni; Klaharn, Merisa; Standal, Therese; Starheim, Kristian K. (Peer reviewed; Journal article, 2021)
      Elevated activity of bone-degrading osteoclasts (OC) contributes to pathological bone degradation in diseases such as multiple myeloma. Several proinflammatory cytokines, including TNF, contribute to osteoclastogenesis. ...

    • TAK1- and IAP-inhibitors as novel approaches to multiple myeloma therapy 

      Håland, Erling (Doctoral theses at NTNU;2024:74, Doctoral thesis, 2024)
      TAK1- and IAP-inhibitors as novel approaches to multiple myeloma therapy Multiple myeloma is a hematological malignancy characterized by accumulation of malignant plasma cells in the bone marrow. This can lead to uncontrolled ...

    • TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma 

      Håland, Erling; Moen, Ingrid Nyhus; Vandsemb, Esten Nymoen; Starheim, Kristian K. (Peer reviewed; Journal article, 2022)
      Objective Multiple myeloma is a haematological malignancy characterized by proliferation of monoclonal plasma cells in the bone marrow. Development of resistance and minimal residual disease remain challenging in the ...